XML 59 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under its Plans is as follows (in thousands, except share, per share data and years):

 

 

 

Number of
Outstanding
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic Value

 

Balance at December 31, 2022

 

 

7,345,444

 

 

$

11.67

 

 

 

8.3

 

 

$

29,806

 

Granted

 

 

2,019,450

 

 

$

13.80

 

 

 

 

 

 

 

Exercised

 

 

(253,545

)

 

$

8.86

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(1,122,157

)

 

$

13.25

 

 

 

 

 

 

 

Balance at December 31, 2023

 

 

7,989,192

 

 

$

12.08

 

 

 

7.8

 

 

$

16,733

 

Vested and expected to vest at December 31, 2023

 

 

7,989,192

 

 

$

12.08

 

 

 

7.8

 

 

$

16,733

 

Exercisable at December 31, 2023

 

 

5,226,145

 

 

$

9.89

 

 

 

7.3

 

 

$

16,596

 

Summary of Fair Value of Stock Option Grants

The assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants under the Plans were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Risk-free interest rate

 

3.5% – 4.7%

 

 

1.5% – 4.2%

 

Expected volatility

 

82% – 87%

 

 

81% – 85%

 

Expected term (in years)

 

5.3 – 6.1

 

 

5.3 – 6.1

 

Expected dividend yield

 

 

 

 

 

 

Summary of Stock-Based Compensation Expense

Stock-based compensation expense has been reported in the statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

7,873

 

 

$

7,235

 

General and administrative

 

 

12,132

 

 

 

9,968

 

Total

 

$

20,005

 

 

$

17,203

 

Summary of Unvested Shares and Unvested Stock Liabilities

A summary of the Company’s unvested shares and unvested stock liabilities is as follows (in thousands, except share data):

 

 

 

Number of
Unvested
Shares

 

 

Weighted-Average Grant Date Fair Value

 

 

Unvested
Stock Liabilities

 

Balance at December 31, 2022

 

 

68,406

 

 

$

1.94

 

 

$

169

 

Vested shares

 

 

(58,087

)

 

$

2.00

 

 

 

(149

)

Balance at December 31, 2023

 

 

10,319

 

 

$

1.57

 

 

$

20

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following:

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Common stock options outstanding

 

 

7,989,192

 

 

 

7,345,444

 

Shares available for issuance under the Plans

 

 

5,198,941

 

 

 

4,012,001

 

Shares available for issuance under the ESPP

 

 

1,142,750

 

 

 

816,478

 

Pre-funded common stock warrants

 

 

503,226

 

 

 

 

Total

 

 

14,834,109

 

 

 

12,173,923